Statutory Rules of Northern Ireland
2014 No. 261

Dangerous Drugs
The Misuse of Drugs (Amendment No.3) Regulations (Northern Ireland) 2014

Made
21st October 2014

Coming into operation
11th November 2014

The Department of Health, Social Services and Public Safety, makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971 (1) as adapted by sections 7(9), 31(4) and 38 of that Act and now vested in it (2) and after consultation with the Advisory Council on the Misuse of Drugs in accordance with section 31(3) of that Act.

Citation, commencement and interpretation

1.—(1) These Regulations may be cited as the Misuse of Drugs (Amendment No. 3) Regulations (Northern Ireland) 2014 and shall come into operation on 11th November 2014.

(2) The Interpretation Act (Northern Ireland) 1954 (3) shall apply to these Regulations as it applies to an Act of the Northern Ireland Assembly.

Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002

2.  The Misuse of Drugs Regulations (Northern Ireland) 2002 (4) shall be amended as provided by regulation 3.

3.  In paragraph 1(a) of Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) after “9-(Hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-6a, 7, 10, 10a-tetrahydrobenzo[c]chromen-1-ol” insert—

“Khat”

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 21st October 2014

Dr. Anne Kilgallen
A senior officer of the
Department of Health, Social Services and Public Safety

EXPLANATORY NOTE

(This note is not part of the Regulation)

These Regulations amend the Misuse of Drugs Regulations (Northern Ireland) 2002 in order to add Khat to Schedule 1 of those Regulations. The Schedule in which a controlled drug is placed primarily affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed and dictates the record keeping, labelling and destruction requirements in relation to that drug.

(1)
1971 c.38. as amended by s.151 of, and Schedule 17 to, the Police Reform and Social Responsibility Act 2011 c.13.

(2)
S.R. & O. (N.I.) 1973 No.504, Article 5(a) and S.I.1999/283 (N.I.1), Article 3(6).

(3)
1954 c.33 (N.I.)

(4)
S.R.2002 No.1 . Relevant amending Regulations are S.R.2014 Nos.158 and 21, S.R.2013 No.78, S.R.2012 No.213, S.R.2011 No.153, S.R.2010 Nos.148 and 247, S.R.2009 No.390, S.R.2007 No.348, S.R.2005 No. 360 and S.R.2003 No.314